Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc. | 13 | 16 | 1 | 4 | €0.62 | €4.10 | 565.628% |
| Bayer AG | 16 | 3 | 3 | 2 | €27.41 | €45.00 | 64.204% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €757.90 | €824.47 | 8.783% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €43.80 | €48.75 | 11.300% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €15.37 | €22.18 | 44.323% |
| Merck KGaA | 3 | 2 | 0 | 1 | €154.85 | €146.00 | -5.715% |
| Adaptimmune Therapeutics PLC ADR | 2 | 1 | 2 | 1 | €1.20 | €2.00 | 66.667% |
| Incyte Corp. | 12 | 2 | 0 | 1 | €63.26 | €78.05 | 23.375% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €261.30 | €315.00 | 20.551% |
| Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €13.40 | €20.55 | 53.327% |
| Brainstorm Cell | 2 | 0 | 1 | 0 | €0.31 | €1.84 | 496.429% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | €8.69 | €26.25 | 202.029% |
| Personalis Inc | 8 | 1 | 0 | 0 | €2.65 | €3.26 | 23.285% |
| XOMA Corp. | 8 | 0 | 1 | 0 | €25.40 | €68.51 | 169.721% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.84 | €5.55 | 95.549% |
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €351.00 | €418.12 | 19.123% |
| aTyr Pharma Inc | 1 | 0 | 0 | 0 | €1.68 | €10.00 | 495.238% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.20 | - | - |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €23.80 | - | - |
| Precision BioSciences Inc | 9 | 0 | 0 | 0 | €0.35 | €10.38 | 2881.839% |
| Taro Pharmaceutical Industries Ltd | 11 | 0 | 2 | 0 | €40.00 | - | - |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €6.45 | €19.50 | 202.537% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | €980.60 | €1,034.6 | 5.510% |
| Exact Sciences | 15 | 0 | 2 | 0 | €44.59 | €77.33 | 73.443% |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.58 | - | - |